×
0 0 -0.00253164556962031 -0.0126582278481013 -0.020253164556962 -0.0253164556962026 -0.0455696202531646 -0.0405063291139241
Stockreport

Conatus Pharma's IDN-7314 shows encouraging action in preclinical studies; shares up 4% premarket [Seeking Alpha]

CONATUS PHARMACEUTICALS INC (CNAT)  More Company Research Source: Seeking Alpha
Last conatus pharmaceuticals inc earnings: 8/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.conatuspharma.com/investor-relations
PDF Conatus Pharma's IDN-7314 shows encouraging action in preclinical studies; shares up 4% premarketConatus Pharmaceuticals (NASDAQ:CNAT) is up4% premarket on light volume in response to itsannouncement that results from preclinical studies of liver disease candidate IDN-7314 have just beenpublished inToxicological Sciences.The data suggest that a pan-caspase inhibitor could potentially reduce excessive clotting in patients with severe liver disease such as primary sclerosing cholangitis (PSC), an Orphan Drug indication.IDN-7314 is an orally available pan-caspase protease inhibitor designed to reduce the activity of enzymes that play a key role in inflammation and cell death (apoptosis). The FDA designated the candidate an Orphan Drug for PSC in June 2017 followed by the EMA four months later.See all stocks on the move »Now read:3 Things In Biotech, April 9: Clovis Hunts Anew, Conatus Falters, Newlink Soul Searches » [Read more]

IMPACT SNAPSHOT EVENT TIME: CNAT
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CNAT alerts
from News Quantified
Opt-in for
CNAT alerts

from News Quantified
Opt-in for
CNAT alerts

from News Quantified